References
- Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379(9824):1436–46. doi:https://doi.org/10.1016/S0140-6736(11)61137-9.
- Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist. 2007;12(10):1237–46. doi:https://doi.org/10.1634/theoncologist.12-10-1237.
- Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1(1):15021. doi:https://doi.org/10.1038/nrdp.2015.21.
- Kaewkhaw R, Rojanaporn D. Retinoblastoma: etiology, modeling, and treatment. Cancers (Basel). 2020;12(8):2304. doi:https://doi.org/10.3390/cancers12082304.
- Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309–16. doi:https://doi.org/10.1016/j.tig.2016.03.002.
- Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31–44. doi:https://doi.org/10.1016/j.pharmthera.2018.01.010.
- Xing L, Zhang L, Feng Y, Cui Z, Ding L. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway. Biomed Pharmacother. 2018;105:326–33. doi:https://doi.org/10.1016/j.biopha.2018.05.141.
- Lyu J, Wang Y, Zheng Q, Hua P, Zhu X, Li J, Li J, Ji X, Zhao P. Reduction of circular RNA expression associated with human retinoblastoma. Exp Eye Res. 2019;184:278–85. doi:https://doi.org/10.1016/j.exer.2019.03.017.
- Hsiao KY, Sun HS, Tsai SJ. Circular RNA - New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–41. doi:https://doi.org/10.1177/1535370217708978.
- Lai X, Eberhardt M, Schmitz U, Vera J. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. Nucleic Acids Res. 2019;47(15):7753–66. doi:https://doi.org/10.1093/nar/gkz638.
- Ding F, Jiang K, Sheng Y, Li C, Zhu H. LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Exp Eye Res. 2020;193:107960. doi:https://doi.org/10.1016/j.exer.2020.107960.
- Ma Z, Liu D, Di S, Zhang Z, Li W, Zhang J, Xu L, Guo K, Zhu Y, Li X, et al. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment. J Pineal Res. 2019;67(2):e12587. doi:https://doi.org/10.1111/jpi.12587.
- Xiong K, Zhang H, Du Y, Tian J, Ding S. Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer. Exp Mol Med. 2019;51(8):1–15. doi:https://doi.org/10.1038/s12276-019-0301-8.
- Jin Q, He W, Chen L, Yang Y, Shi K, You Z. MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9. Exp Ther Med. 2018;16(3):1663–70. doi:https://doi.org/10.3892/etm.2018.6405.
- Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42. doi:https://doi.org/10.1080/15476286.2015.1128065.
- Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015:4. doi:https://doi.org/10.7554/eLife.05005.
- Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84(12):937–44. doi:https://doi.org/10.1007/s12098-017-2395-0.
- Sun Z, Zhang A, Hou M, Jiang T. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020;11(1):949–57. doi:https://doi.org/10.1080/21655979.2020.1814670.
- Zhao W, Wang S, Qin T, Wang W. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3. J Cell Biochem. 2020;121(7):3516–25. doi:https://doi.org/10.1002/jcb.29631.
- Zhang L, Wu J, Li Y, Jiang Y, Wang L, Chen Y, Lv Y, Zou Y, Ding X. Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis. Cancer Cell Int. 2020;20(1):301. doi:https://doi.org/10.1186/s12935-020-01396-4.
- Chen NN, Chao DL, Li XG. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochem Funct. 2020;38(8):1036–46. doi:https://doi.org/10.1002/cbf.3535.
- Zheng F, Wang M, Li Y, Huang C, Tao D, Xie F, Zhang H, Sun J, Zhang C, Gu C, et al. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression. Cancer Lett. 2019;460:139–51. doi:https://doi.org/10.1016/j.canlet.2019.06.018.
- Chen Q, Liu T, Bao Y, Zhao T, Wang J, Wang H, Wang A, Gan X, Wu Z, Wang L. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Cancer Lett. 2020;469:68–77. doi:https://doi.org/10.1016/j.canlet.2019.10.017.
- Geng G, Liu X, Xu A, Lu Z, Chen K, He J, Qi D, Yuan X. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer. J Gene Med. 2020;22(5):e3166. doi:https://doi.org/10.1002/jgm.3166.
- Li JM, Zhou J, Xu Z, Huang HJ, Chen MJ, Ji JS. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma. J Cell Biochem. 2018;119(7):5143–52. doi:https://doi.org/10.1002/jcb.26526.
- Zeng G, Xun W, Wei K, Yang Y, Shen H. MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells. Oncol Rep. 2016;36(3):1475–82. doi:https://doi.org/10.3892/or.2016.4916.
- Zhang Y, Wu D, Xia F, Xian H, Zhu X, Cui H, Huang Z. Downregulation of HDAC9 inhibits cell proliferation and tumor formation by inducing cell cycle arrest in retinoblastoma. Biochem Biophys Res Commun. 2016;473(2):600–06. doi:https://doi.org/10.1016/j.bbrc.2016.03.129.
- Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, Deubzer HE, Lodrini M, Taylor MD, Von Deimling A, et al. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res. 2010;16(12):3240–52. doi:https://doi.org/10.1158/1078-0432.CCR-10-0395.
- Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147–60. doi:https://doi.org/10.1016/j.semcancer.2019.05.012.
- Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11(9):797. doi:https://doi.org/10.1038/s41419-020-02998-6.